Finance

Lists
DVA:NYSE
Davita Inc
USD 175,19
-1,62%
(-2,88) 1D
USD 175,36
+0,10% (+0,17)
Pre-market
Closed: 29 Sep., 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DVA...
Open
USD 176,92
High
USD 176,98
Low
USD 174,08
Mkt. cap
11,18 mjd
Avg. vol.
672,40 k
Volume
1,13 k
P/E ratio
14,35
52-wk high
USD 247,49
52-wk low
USD 101,00
EPS
USD 12,21
Beta
0,83
Shares outstanding
63,80 m
No. of employees
78 k
Open
USD 176,92
High
USD 176,98
Low
USD 174,08
Mkt. cap
11,18 mjd
Avg. vol.
672,40 k
Volume
1,13 k
P/E ratio
14,35
52-wk high
USD 247,49
52-wk low
USD 101,00
EPS
USD 12,21
Beta
0,83
Shares outstanding
63,80 m
No. of employees
78 k
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees78 k
Founded1992
HeadquartersDenver, Colorado, Verenigde State van Amerika
SectorHealth care provider
Websitedavita.com
Analyst ratings
Based on 6 analysts giving stock ratings to DVA in the past 3 months
Buy
Buy
3
Hold
2
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for DVA in the last 3 months.
Highest
Current USD 175,19
USD 270,00 (+54,12%)
Average
USD 238,80 (+36,31%)
Lowest
USD 215,00 (+22,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Hold
Maintained
USD 224,00
+27,9%
08/11/2026
David S Macdonald
Truist Financial
Hold
Maintained
USD 215,00
+22,7%
08/11/2026
Ryan Langston
TD Cowen
Buy
Upgraded
USD 220,00
+25,6%
08/07/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
USD 265,00
+51,3%
08/05/2026
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
-
-
08/05/2026
A.J. Rice
UBS
Buy
Reiterated
USD 270,00
+54,1%
07/10/2026
Last report
04 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 4,02 / USD 3,88
+3,55%beat
Revenue / Est. (USD)
3,55 mjd / 3,49 mjd
+1,73%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,42 mjd
3,62 mjd
3,42 mjd
3,55 mjd
Cost of goods sold
2,33 mjd
2,41 mjd
2,34 mjd
2,39 mjd
Cost of revenue
2,33 mjd
2,41 mjd
2,34 mjd
2,39 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 m
472,36 m
421,91 m
423,46 m
Operating expense
580,16 m
659,06 m
599,74 m
591,27 m
Total operating expenses
2,91 mjd
3,07 mjd
2,94 mjd
2,98 mjd
Operating income
507,30 m
551,20 m
473,55 m
570,82 m
Other non operating income
-17,26 m
-21,03 m
639,00 k
4,47 m
EBT including unusual items
308,80 m
382,76 m
341,23 m
435,01 m
EBT excluding unusual items
351,55 m
391,79 m
341,23 m
437,04 m
Income tax expense
68,55 m
76,73 m
66,20 m
91,79 m
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 m
234,22 m
197,53 m
265,40 m
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 m
-148,25 m
-141,30 m
-146,42 m
Net interest expenses
-148,66 m
-148,25 m
-141,30 m
-146,42 m
Depreciation and amortization charges
177,49 m
186,70 m
177,83 m
167,81 m
EBITDA
684,80 m
737,91 m
651,38 m
738,62 m
Gain or loss from assets sale
-
-17,55 m
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme